Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib

Fabio P.S. Santos, Yesid Alvarado, Hagop Kantarjian, Dushyant Verma, Susan O'Brien, Gloria Mattiuzzi, Farhad Ravandi, Gautam Borthakur, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint Dive into the research topics of 'Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences